Seminar on Rhinoplasty May 17 by Dr. Ronald H Schuster – Board Certified Plastic Surgeon in Baltimore, Maryland
May 14, 2012

ANNOUNCEMENT – I will be speaking about Rhinoplasty on Thursday, May 17 at Lifebridge Health and Fitness in Pikesville, from 7-8 pm. I will discuss all different aspect of rhinoplasty )nasal surgery) including common problems, surgery, cost and recovery. I will show many examples of a variety of different problems and how they were successfully click to read more →



SPECIAL SAVINGS ON DYSPORT from Dr. Ronald Schuster, Board Certified Plastic Surgeon in Baltimore, Maryland
May 3, 2012

Now through the month of June we will be offering a special matching discount on all Dysport treatments. Medicis, the distributor of Dysport is offering $50 rebate on all treatments given between May 1 and June 31. In order to help kick off the Spring season my office will match that offer. This results in click to read more →



Coolsculpting from Dr. Ronald Schuster in Baltimore, Maryland – Part II
April 15, 2012

Ok, Ok. A lot of people have been asking about the Coolsculpting. So here’s the scoop. Coolsculpting is the new FDA approved technology for non-surgical fat removal. Made by Zeliq, Coolsculpting is the process of removing fat by freezing, called cryolipolysis. The basic research was done at Harvard. What they foiund, and confirmed through extensive research, click to read more →



Coolsculpting from Dr. Ronald Schuster in Baltimore, Maryland
March 22, 2012

COOLSCULPTING – BEGINNING IN APRIL I am excited to announce that we will be offering Coolsculpting beginning in April. Coolsculpting is a new FDA approved technology to reduce fat through non-surgical freezing technology. It is the only FDA machine in its class. Technically referred to as cryolipolysis, Coolsculpting is able to reduce fat in many click to read more →



FDA approves new silicone gel implant
March 11, 2012

The Food and Drug Administration (FDA) today approved a silicone gel-filled breast implant manufactured by Sientra Inc. to increase breast size (augmentation) in women at least 22 years old and to rebuild breast tissue (reconstruction) in women of any age. As a condition of approval, Sientra is required to conduct post-approval studies that will assess click to read more →